Assessing the Efficacy and Safety of an 11ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. (2017)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2196/resprot.7806

PubMed Identifier: 28923789

Publication URI: http://europepmc.org/abstract/MED/28923789

Type: Journal Article/Review

Volume: 6

Parent Publication: JMIR research protocols

Issue: 9

ISSN: 1929-0748